NICE guidance (NG28) recommends: HbA1c monitoring every 36 months until stable, then 6-monthly Renal function tests at least annually (more frequently if pre-existing kidney disease) Weight and BMI tracking to assess treatment response Blood pressure monitoring , as weight loss may allow reduction in antihypertensive medications Appropriate retinopathy screening for patients with diabetes, particularly those with pre-existing retinopathy taking semaglutide Communication with your healthcare team is vital
However, the transition period may involve temporary irregularities as the body adjusts to new metabolic parameters
Copper signalling: causes and consequences Julianna Kardos, Lszl Hja, gnes Simon, et al
FEBS Letters, 176 , 381384
Refined carbohydrates and processed foods must be minimized, especially after stopping medication
No sample size calculation was performed for any study, however, for all studies, we typically start with an n = 10, which is usually sufficient to see statistically different changes between the groups, as well as a sufficient sample size for subsequent analyses on tissues and serum
